Matthew Call
CIK 1816207 · Chief Operating Officer · last filed 2025-08-29
Matthew Call is a Chief Operating Officer who has filed 10 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for ITOS, was dated Aug 29, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
10
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. (ITOS) Delisted | Chief Operating Officer | 0 | $10.15 | $0 | $0 | 10 | 2025-08-29 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-29 | iTeos Therapeutics, Inc. (ITOS) Delisted | Mixed | −161,898 | $0 | EDGAR |
| 2025-03-11 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | +24,000 | $0 | EDGAR |
| 2024-03-08 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-07 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | +44,000 | $0 | EDGAR |
| 2023-03-29 | iTeos Therapeutics, Inc. (ITOS) Delisted | Exer (M) | +40,226 | $118.7K | EDGAR |
| 2023-03-10 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-14 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-05 | iTeos Therapeutics, Inc. (ITOS) Delisted | Exer (M) | +53,672 | $158.3K | EDGAR |
| 2021-06-25 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-03 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |